Almirall, S.A. (BME:ALM)

Market Cap	2.15B
Revenue (ttm)	990.63M
Net Income (ttm)	10.15M
Shares Out	213.47M
EPS (ttm)	0.05
PE Ratio	209.84
Forward PE	41.97
Dividend	0.19 (1.89%)
Ex-Dividend Date	May 17, 2024

Volume	49,939
Average Volume	153,083
Open	9.92
Previous Close	10.07
Day's Range	9.82 - 10.00
52-Week Range	8.03 - 10.45
Beta	0.30
RSI	54.67
Earnings Date	Jul 25, 2025

About Almirall

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immun...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1943
• Employees: 2,026
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ALM